4.6 Article

Prevalence of Dementia 7.5 Years after Coronary Artery Bypass Graft Surgery

Journal

ANESTHESIOLOGY
Volume 125, Issue 1, Pages 62-71

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ALN.0000000000001143

Keywords

-

Categories

Funding

  1. Australian National Health and Medical Research Council, Canberra, Australian Capital Territory, Australia [140510]
  2. Australian and New Zealand College of Anaesthetists Research Grant, Melbourne, Victoria, Australia

Ask authors/readers for more resources

Background: Although postoperative cognitive dysfunction (POCD) is well described after coronary artery bypass graft (CABG) surgery, a major concern has been that a progressive decline in cognition will ultimately lead to dementia. Since dementia interferes with the ability to carry out daily functions, the impact has far greater ramifications than cognitive decline defined purely by a decreased ability to perform on a battery of neurocognitive tests. The authors hypothesized that early cognitive impairment measured as baseline cognitive impairment is associated with an increased risk of long - term dementia. Methods: The authors conducted a prospective longitudinal study on 326 patients aged 55 yr and older at the time of undergoing CABG surgery. Dementia was classified by expert opinion on review of performance on the Clinical Dementia Rating Scale and several other assessment tasks. Patients were also assessed for POCD at 3 and 12 months and at 7.5 yr using a battery of neuropsychologic tests and classified using the reliable change index. Associations were assessed using univariable analysis. Results: At 7.5 yr after CABG surgery, the prevalence of dementia was 36 of 117 patients (30.8%; 95% CI, 23 to 40). POCD was detected in 62 of 189 patients (32.8%; 95% CI, 26 to 40). Due to incomplete assessments, the majority (113 patients), but not all, were assessed for both dementia and POCD. Fourteen of 32 (44%) patients with dementia were also classified as having POCD. Preexisting cognitive impairment and peripheral vascular disease were both associated with dementia 7.5 yr after CABG surgery. POCD at both 3 (odds ratio, 3.06; 95% CI, 1.39 to 9.30) and 12 months (odds ratio, 4.74; 95% CI, 1.63 to 13.77) was associated with an increased risk of mortality by 7.5 yr. Conclusions: The prevalence of dementia at 7.5 yr after CABG surgery is greatly increased compared to population prevalence. Impaired cognition before surgery or the presence of cardiovascular disease may contribute to the high prevalence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis

James D. Doecke, Virginia Perez-Grijalba, Noelia Fandos, Christopher Fowler, Victor L. Villemagne, Colin L. Masters, Pedro Pesini, Manuel Sarasa

NEUROLOGY (2020)

Article Clinical Neurology

Aggregation of Abnormal Memory Scores and Risk of Incident Alzheimer's Disease Dementia: A Measure of Objective Memory Impairment in Amnestic Mild Cognitive Impairment

Nicholas Bradfield, Kathryn A. Ellis, Greg Savage, Paul Maruff, Samantha Burnham, David Darby, Nicola T. Lautenschlager, Ralph N. Martins, Colin L. Masters, Stephanie R. Rainey-Smith, Joanne Robertson, Christopher Rowe, Michael Woodward, David Ames

Summary: Aggregating abnormal memory scores may predict the risk of progression from MCI to AD dementia and provide prognostic stratification for individuals.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2021)

Article Clinical Neurology

The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans

Mohamad Habes, Raymond Pomponio, Haochang Shou, Jimit Doshi, Elizabeth Mamourian, Guray Erus, Ilya Nasrallah, Lenore J. Launer, Tanweer Rashid, Murat Bilgel, Yong Fan, Jon B. Toledo, Kristine Yaffe, Aristeidis Sotiras, Dhivya Srinivasan, Mark Espeland, Colin Masters, Paul Maruff, Jurgen Fripp, Henry Volzk, Sterling C. Johnson, John C. Morris, Marilyn S. Albert, Michael Miller, R. Nick Bryan, Hans J. Grabe, Susan M. Resnick, David A. Wolk, Christos Davatzikos

Summary: The relationship between white matter hyperintensities and various factors such as brain aging, AD neuropathology, cognitive decline, and Aβ positivity after age 65 have been observed in a large MRI database. The Brain Chart established can quantify brain-aging trajectories and provide systematic evaluation of brain-aging patterns relative to a large consortium. Brain aging, AD-like atrophy, and WMHs were shown to be better predictors of cognition than chronological age in MCI/AD subjects.

ALZHEIMERS & DEMENTIA (2021)

Article Immunology

Acute neuroimmune stimulation impairs verbal memory in adults: A PET brain imaging study

Eric A. Woodcock, Ansel T. Hillmer, Christine M. Sandiego, Paul Maruff, Richard E. Carson, Kelly P. Cosgrove, Robert H. Pietrzak

Summary: This study found that LPS administration in healthy adults can impair memory processes, specifically affecting verbal learning and recall, hippocampal memory processes. Furthermore, LPS also leads to increased neuroinflammation, which is correlated with decreased performance in memory in the hippocampus, putamen, and thalamus. This experimental paradigm may be useful for investigating the mechanistic relationships between neuroinflammatory signaling and cognitive dysfunction in psychiatric and neurologic disorders.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Article Clinical Neurology

Association of deficits in short-term learning and Aβ and hippocampal volume in cognitively normal adults

Yen Ying Lim, Jenalle E. Baker, Loren Bruns, Andrea Mills, Christopher Fowler, Jurgen Fripp, Stephanie R. Rainey-Smith, David Ames, Colin L. Masters, Paul Maruff

NEUROLOGY (2020)

Article Medicine, Research & Experimental

Evaluation of the effect of Cooled HaEmodialysis on Cognitive function in patients suffering with end-stage KidnEy Disease (E-CHECKED): feasibility randomised control trial protocol

Indranil Dasgupta, Aghogho Odudu, Jyoti Baharani, Niall Fergusson, Helen Griffiths, John Harrison, Paul Maruff, G. Neil Thomas, Gavin Woodhall, Samir Youseff, George Tadros

TRIALS (2020)

Article Behavioral Sciences

BDNF VAL66MET polymorphism and memory decline across the spectrum of Alzheimer's disease

Yen Ying Lim, Simon M. Laws, Stephanie Perin, Robert H. Pietrzak, Christopher Fowler, Colin L. Masters, Paul Maruff

Summary: The study examined the impact of BDNF on memory and disease progression in different stages of AD. Results showed that in A beta+ CN individuals, the Met66 genotype was associated with greater memory decline and increased risk of progression to MCI/AD over time. Meanwhile, in A beta+ MCI individuals, the Met66 genotype did not have an effect on memory decline or progression to AD. In A beta+ AD individuals, Val66 homozygotes exhibited greater memory decline, while Met66 carriers performed consistently at a severely impaired level.

GENES BRAIN AND BEHAVIOR (2021)

Article Neurosciences

Phase 1 randomized study on the safety, tolerability, and pharmacodynamic cognitive and electrophysiological effects of a dopamine D1 receptor positive allosteric modulator in patients with schizophrenia

Amit Desai, Lauren Benner, Ruishan Wu, Lev Gertsik, Paul Maruff, Gregory A. Light, Tolga Uz, Gerard J. Marek, Tong Zhu

Summary: ASP4345, a novel dopamine D-1 receptor positive allosteric modulator, shows good safety and potential improvement in cognitive function in patients with schizophrenia/schizoaffective disorder. Positive changes in neurophysiological biomarkers also suggest improvement in information processing. Further studies with larger patient populations are needed to confirm these findings.

NEUROPSYCHOPHARMACOLOGY (2021)

Article Clinical Neurology

The impact of the wake maintenance zone on attentional capacity, physiological drowsiness, and subjective task demands during sleep deprivation

William Ryan McMahon, Suzanne Ftouni, Charmaine Diep, Jinny Collet, Steven W. Lockley, Shantha M. W. Rajaratnam, Paul Maruff, Sean P. A. Drummond, Clare Anderson

Summary: This study aimed to investigate the impact of the Wake Maintenance Zone (WMZ) on measures of drowsiness, attention, and subjective performance under rested and sleep deprived conditions. The results showed that the WMZ did not mitigate the adverse effects of sleep deprivation on drowsiness, sustained attention, response inhibition, and self-rated concentration and difficulty, but it did improve measures of sustained attention and subjective concentration and task difficulty compared to the pre-WMZ during sleep deprivation.

JOURNAL OF SLEEP RESEARCH (2021)

Article Geriatrics & Gerontology

Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF A,B42 moderates the association between insulin resistance and increased CSF tau levels

Amy Woodfield, Tenielle Porter, Israa Gilani, Siti Noordin, Qiao-Xin Li, Steven Collins, Ralph N. Martins, Paul Maruff, Colin L. Masters, Christopher C. Rowe, Victor L. Villemagne, Vincent Dore, Philip Newsholme, Simon M. Laws, Giuseppe Verdile

Summary: Insulin resistance is implicated in Alzheimer's disease biomarker progression and cognitive decline. Cerebrospinal fluid (CSF) tau does not directly influence the association between insulin resistance and cognition, but CSF Aβ42 moderates the relationship between them.

NEUROBIOLOGY OF AGING (2022)

Article Psychology, Educational

Development of complex executive function over childhood: Longitudinal growth curve modeling of performance on the Groton Maze Learning Task

Thomas B. McGuckian, Peter H. Wilson, Rich D. Johnston, Shahin Rahimi-Golkhandan, Jan Piek, Dido Green, Jeffrey M. Rogers, Paul Maruff, Bert Steenbergen, Scott Ruddock

Summary: This longitudinal study examined the development of children's complex executive function (EF) using the Groton Maze Learning Task (GMLT). A total of 147 children (61 males, ages 5.5-11 years) were recruited from six multicultural primary schools in Melbourne and Perth, Australia. The study spanned from 2010 to 2012, with assessments on the GMLT conducted every 6 months. Growth curve models indicated a quadratic growth trajectory in each measure of error, reflecting visuospatial memory, executive control, and complex EF. The ability to apply rules for action, a key aspect of complex EF, developed rapidly during early-to-mid childhood.

CHILD DEVELOPMENT (2023)

Article Psychology, Clinical

Multidomain Modifiable Dementia Risk Factors Are Associated With Poorer Cognition in Midlife

Lisa Bransby, Emily Rosenich, Rachel F. Buckley, Nawaf Yassi, Matthew P. Pase, Paul Maruff, Yen Ying Lim

Summary: This study aimed to determine the frequency and co-occurrence of modifiable dementia risk factors (MDRFs) in a large sample of middle-aged adults. The results showed that most individuals reported MDRFs in two or more domains, and these multidomain MDRFs were related to poorer cognition.

NEUROPSYCHOLOGY (2023)

Article Clinical Neurology

Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies

John J. Alam, Paul Maruff, Susan R. Doctrow, Hui-May Chu, Jennifer Conway, Stephen N. Gomperts, Charlotte Teunissen

Summary: This study evaluates the relationship between plasma tau phosphorylated at residue 181 (ptau181), a biomarker of Alzheimer disease (AD) copathology, and the treatment effects of the p38 alpha kinase inhibitor neflamapimod in patients with dementia with Lewy bodies (DLB). The results suggest that DLB patients with lower pretreatment ptau181 levels may show better treatment response to neflamapimod, with improvement in attention, cognitive assessment, and daily functioning. Plasma biomarkers of AD copathology should be considered as stratification variables in DLB clinical trials.

NEUROLOGY (2023)

Article Psychology, Mathematical

Assessing the utility of a virtual-reality neuropsychological test battery, 'CONVIRT', in detecting alcohol-induced cognitive impairment

Isabella Amato, Aleshia Nanev, Stefan Piantella, Kira-Elise Wilson, Rowena Bicknell, Rachael Heckenberg, Ben Horan, Paul Maruff, Bradley Wright

Summary: The study investigated the sensitivity and reliability of new technologies in measuring cognitive function under acute alcohol intoxication, finding that the CONVIRT test battery was sensitive to changes in cognitive impairment induced by alcohol and demonstrated strong test-retest reliability.

BEHAVIOR RESEARCH METHODS (2021)

Article Clinical Neurology

The Computerized Cognitive Composite (C3) in A4, an Alzheimer's Disease Secondary Prevention Trial

Kathryn V. Papp, D. M. Rentz, P. Maruff, C. -K. Sun, R. Raman, M. C. Donohue, A. Schembri, C. Stark, M. A. Yassa, A. M. Wessels, R. Yaari, K. C. Holdridge, P. S. Aisen, R. A. Sperling

Summary: Computerized cognitive assessments, such as the tablet-based Computerized Cognitive Composite (C3), show feasibility and validity in AD prevention trials. The C3 was found to be feasible for clinically normal older adults and moderately correlated with standard cognitive measures. Additionally, individuals with A beta+ performed worse on the C3 compared to those with A beta-, indicating its potential as a sensitive cognitive outcome measure.

JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE (2021)

No Data Available